Medico Remedies Limited (NSE:MEDICO)

Market Cap	3.14B -36.1%
Revenue (ttm)	1.91B +26.4%
Net Income	115.99M +31.0%
EPS	1.40 +32.1%
Shares Out	n/a
PE Ratio	27.05
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	212,118
Average Volume	549,341
Open	38.45
Previous Close	38.32
Day's Range	35.20 - 38.67
52-Week Range	30.22 - 62.48
Beta	0.09
RSI	44.30
Earnings Date	May 30, 2026

About Medico Remedies

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and ster...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1994
• Employees: 213
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MEDICO

Financial Performance

In fiscal year 2025, Medico Remedies's revenue was 1.51 billion, an increase of 4.15% compared to the previous year's 1.45 billion. Earnings were 100.93 million, an increase of 21.74%.